PharmaVision

What PharmaVision does

PharmaVision Sanayi ve Ticaret Anonim Şirketi is a privately held Turkish pharmaceutical manufacturing and trading company headquartered in the Topkapi/Zeytinburnu district of Istanbul. Founded in 1954, the company has operated continuously for over seven decades in Turkey's pharmaceutical sector, supplying pharmaceutical products and services to the domestic and broader European market. The company employs between 251 and 500 people and is structured as a Turkish joint stock company (Anonim Şirketi), with no public listing and no disclosed institutional or private equity ownership.

The company's documented strengths are concentrated in operational quality and regulatory compliance rather than disclosed product or technology differentiation. It maintains an unusually broad portfolio of management system certifications — covering environmental management (ISO 14001), occupational health and safety (ISO 45001), information security (ISO 27001), laboratory competence (ISO 17025), energy management (ISO 50001), business continuity (ISO 22301), privacy (ISO 27701), asset management (ISO 55001), and risk management (ISO 31000) — and has received the Deloitte Best Managed Companies award. The company emphasizes its 1954 heritage and longstanding trust as commercial differentiators. Specific pharmaceutical product lines, formulation capabilities, manufacturing capacity, R&D investment, and customer segments are not disclosed in available source material, and the company has not publicly disclosed any AI, machine learning, or advanced technology capabilities.

The business model is not publicly detailed: there is no pricing model, no subscription structure, no disclosed revenue figure, and no customer segment breakdown. Commercial activity appears to be conducted through a corporate website and industry association engagement (notably TKSD, the Turkish Chemical Industry Association), with the website also referencing an E-supply digital ordering platform. The company engages in corporate social responsibility through partnerships with the Turkish Education Foundation (TEV) and the Özgen Berkol Doğan Science Fiction Library. Revenue mechanics, distribution channels, and end-customer composition remain unverified.

Name

PharmaVision

Legal name

PharmaVision Sanayi ve Ticaret Anonim Şirketi

Website

https://pharmavision.com.tr

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

251–500 employees

Short description

PharmaVision is a privately held Turkish pharmaceutical manufacturer and trader, founded in 1954 and headquartered in Istanbul. The company supplies pharmaceutical products to the Turkish and broader European market, with operations supported by an extensive portfolio of ISO management system certifications.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

Keywords

• Pharmaceutical manufacturing
• Generic drug production
• Medicinal products
• Pharmaceutical formulations
• Pharmaceutical trading

Headquarters

HQ city

Istanbul

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

PharmaVision is a Turkish pharmaceutical manufacturing company established in 1954, headquartered in Istanbul's Topkapi/Zeytinburnu district. The company manufactures pharmaceutical products and engages in trading activities within Turkey's pharmaceutical industry, operating from a facility of 251-500 employees with comprehensive management system certifications covering environmental, occupational health and safety, information security, energy management, business continuity, and asset management systems.

Product overview

PharmaVision Sanayi ve Ticaret Anonim Şirketi is a pharmaceutical manufacturing company established in 1954, headquartered at Davutpaşa Caddesi No: 145 34010 Topkapı / Zeytinburnu / İstanbul, Turkey. The company maintains numerous management system certifications including environmental, occupational health and safety, information security, energy management, business continuity, and asset management systems. Specific pharmaceutical products are not detailed in the available source material, which focuses primarily on corporate news, certifications, and cookie policies.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• Türk Eğitim Vakfı (Turkish Education Foundation)minorOthersPharmaVision provides scholarship support to the Turkish Education Foundation, demonstrating commitment to educational causes and social responsibility initiatives.
• Özgen Berkol Doğan Bilimkurgu Kütüphanesi (Science Fiction Library)minorOthersPharmaVision supports the Özgen Berkol Doğan Science Fiction Library, indicating engagement in cultural and educational sponsorship activities.
• Türkiye Kimya Sanayicileri Derneği (Turkish Chemical Industry Association)minorOthersPharmaVision participates in TKSD events, including the association's 40th founding anniversary celebration. Active member of the Turkish chemical industry association.

Scale indicators1 record

Recent moves7 records

Expansion highlights3 records

Direct peers

• Abdi İbrahim: Turkey's largest domestic pharmaceutical manufacturer, headquartered in Istanbul. Directly comparable as a Turkish pharma manufacturer of branded and generic medicines with comparable headcount scale, European export orientation, and similar ISO-driven compliance posture.
• Eczacıbaşı (Eczacıbaşı İlaç): Major Turkish pharmaceutical and consumer health conglomerate with manufacturing operations and international presence. Directly comparable as a Turkey-based pharma manufacturer targeting both domestic and European markets with diversified branded portfolios.
• Ali Raif İlaç: Turkish pharmaceutical manufacturer with similar headcount scale and product breadth in generics and branded medicines. Directly comparable as a fellow mid-sized Istanbul-based pharma manufacturer serving the Turkish and broader regional market.
• Polifarma: Turkey-based pharmaceutical manufacturer specializing in sterile injectable and generic products. Comparable as a mid-sized Turkish pharma manufacturer with similar regulatory profile and European export ambitions.
• World Medicine (Dünya İlaç): Turkish pharmaceutical manufacturer with European-focused export operations and a generic-portfolio mix. Comparable as a similarly scaled Turkish pharma manufacturer competing in EU generics tenders.
• Atabay Pharmaceuticals: Established Turkish pharmaceutical manufacturer (founded 1939) with API and finished-dose capabilities. Comparable as a heritage Turkish pharma manufacturer of similar vintage and scale, sharing the same regulatory and export dynamics.

Broad incumbents

• Sandoz: Global leader in generics and biosimilars spun out from Novartis. Comparable as a large-scale pharmaceutical manufacturer operating across Europe with similar generic-portfolio economics and contract manufacturing orientation.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with extensive European footprint. Comparable as a broad incumbent in off-patent pharmaceuticals with manufacturing scale that dominates the same European tender and distribution channels PharmaVision serves.
• Stada Arzneimittel: European-focused generics and specialty pharma company with strong presence in Turkey and Eastern Europe. Comparable as a European-edge manufacturer competing in the same generic-pharma value chain PharmaVision operates in.
• Hikma Pharmaceuticals: Multinational pharmaceutical company with significant MENA and European operations. Comparable as a mid-to-large generic and specialty manufacturer with similar regulatory and export-driven growth strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/pharmavision_tr
• Facebookfacebook.com/pharmavisionyazstaji
• LinkedInlinkedin.com/company/phv

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaVision